Home Cart Sign in  
Chemical Structure| 865362-74-9 Chemical Structure| 865362-74-9

Structure of FR 180204
CAS No.: 865362-74-9

Chemical Structure| 865362-74-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

FR 180204 is an ATP-competitive and selective ERK inhibitor, inhibiting ERK1 and ERK2 with IC50 values of 0.51 μM (Ki = 0.31 μM) and 0.33 μM (Ki = 0.14 μM), respectively.

Synonyms: ERK Inhibitor II

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Zhao, Bin ; Qiu, Xinjie ; Wang, Chong ; Wu, Shaobang ; Yin, Xin ; Zhang, Lina , et al.

Abstract: Oral ulcer (OU) is a highly prevalent mucosal disease characterized by persistent epithelial disruption. The primary challenge in its prolonged healing process is the disorder of re-epithelialization. This study develops a self-assembled hydrogel platform based on the natural small molecule , which overcomes the re-epithelialization barrier through the synergistic effects of early growth response factor 1 (EGR1) gene programming and microenvironment remodeling. In this hydrogel, formed supramolecular structures via hydrogen bonds and p–p interactions without structural modification. In vitro experiments confirm that rutin-based self-assembled hydrogel (RUTG) possesses excellent sustained-release properties and biocompatibility. Moreover, RUTG specifically regulates the transcriptional activation and translation of EGR1, thereby mediating the expression of re-epithelialization-related protein SOX9, and ultimately accelerating cell proliferation and migration as well as promoting re-epithelialization. Additionally, RUTG demonstrates beneficial anti-inflammatory and properties, effectively remodeling the local microenvironment. In vivo studies using an oral ulcer model further confirm that RUTG could significantly accelerate the re-epithelialization process, shorten the ulcer healing cycle, and achieve functional tissue reconstruction. Collectively, this carrier-free hydrogel system, which integrates gene programming with microenvironment modulation to achieve efficient re-epithelialization, holds promise for introducing novel approaches to the treatment of oral ulcers.

Keywords: EGR1 ; oral ulcer ; re-epithelialization ; ; self-assembly

Purchased from AmBeed:

Alternative Products

Product Details of FR 180204

CAS No. :865362-74-9
Formula : C18H13N7
M.W : 327.34
SMILES Code : NC1=NNC2=NN=C(C3=C4C=CC=CN4N=C3C5=CC=CC=C5)C=C21
Synonyms :
ERK Inhibitor II
MDL No. :MFCD14585805
InChI Key :XVECMUKVOMUNLE-UHFFFAOYSA-N
Pubchem ID :11493598

Safety of FR 180204

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Related Pathways of FR 180204

MAPK

Isoform Comparison

Biological Activity

Target
  • ERK2

    ERK2, Ki:0.14 μM

  • ERK1

    ERK1, Ki:0.31 μM

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.05mL

0.61mL

0.31mL

15.27mL

3.05mL

1.53mL

30.55mL

6.11mL

3.05mL

References

 

Historical Records

Categories